Publication scheme
NHS Kernow has followed guidance from the Information Commissioner and adopted its publication scheme for healthcare.
This scheme aims to provide you with information on the following:
- who we are and what we do
- what we spend and how we spend it
- what are our priorities and how are we doing
- our policies and procedures
Where possible, this information will be available on our website. However, some information may only be available as hard copy or other media.
You can also check if the information has been published in our disclosure log, which contains responses to all our FOI requests.
Rebate scheme
Prescribing rebates
NHS Kernow has a policy to agree and consider future rebates, and has arrangements for the drugs below.
Attention deficit hyperactivity disorder: Xaggitin
Company: Ethypharm
Product: Xaggitin
Type: Used to treat attention deficit hyperactivity disorder (ADHD)
Start date: 1 August 2017
End date: Rolling
Aligned to PrescQIPP: Yes
Product: Xaggitin
Type: Used to treat attention deficit hyperactivity disorder (ADHD)
Start date: 1 August 2017
End date: Rolling
Aligned to PrescQIPP: Yes
Anti-coagulant: Edoxaban
Company: Daiichi Sankyo
Product: Edoxaban
Type: Anti coagulant
Start date: 1 April 2018
End date: 31 December 2022
Aligned to PrescQIPP: Yes
Product: Edoxaban
Type: Anti coagulant
Start date: 1 April 2018
End date: 31 December 2022
Aligned to PrescQIPP: Yes
Anti-psychotic medicine: Zaluron XL (Quetiapine XL)
Company: Fontus Health Limited
Product: Zaluron XL (Quetiapine XL)
Type: Anti-psychotic medicine
Start date: 1 August 2019
End date: 30 July 2024
Aligned to PrescQIPP: Yes
Product: Zaluron XL (Quetiapine XL)
Type: Anti-psychotic medicine
Start date: 1 August 2019
End date: 30 July 2024
Aligned to PrescQIPP: Yes
Atypical anti-psychotic medicine: Quetiapine Biquelle
Company: Aspire Pharma Limited
Product: Quetiapine – Biquelle
Type: Atypical anti-psychotic medicine
Start date: 1 April 2020
End date: 31 March 2021
Aligned to PrescQIPP: Yes
Product: Quetiapine – Biquelle
Type: Atypical anti-psychotic medicine
Start date: 1 April 2020
End date: 31 March 2021
Aligned to PrescQIPP: Yes
DVT: Rivaroxaban
Company: Bayer
Product: Rivaroxaban
Type: Prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
Start date: 1 July 2020
End date: 1 December 2021
Aligned to PrescQIPP: Yes
Product: Rivaroxaban
Type: Prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs
Start date: 1 July 2020
End date: 1 December 2021
Aligned to PrescQIPP: Yes
Emollient for eczema: Balneum
Company: Almirall Limited
Product: Balneum
Type: Emollient for eczema
Start date: 23 June 2020
End date: 22 June 2022
Aligned to PrescQIPP: Yes
Product: Balneum
Type: Emollient for eczema
Start date: 23 June 2020
End date: 22 June 2022
Aligned to PrescQIPP: Yes
Inhaler: Clenil Modulite
Company: Chiesi Limited
Product: Clenil Modulite
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Product: Clenil Modulite
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Inhaler: Fostair Nexthaler
Company: Chiesi Limited
Product: Fostair Nexthaler
Type: Inhaler
Start date: 1 May 2021
End date: 30 April 2023
Aligned to PrescQIPP: Yes
Product: Fostair Nexthaler
Type: Inhaler
Start date: 1 May 2021
End date: 30 April 2023
Aligned to PrescQIPP: Yes
Inhaler: Fostair pMDI
Company: Chiesi Limited
Product: Fostair pMDI
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Product: Fostair pMDI
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Inhaler: Sereflo
Company: CIPLA
Product: Sereflo
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Product: Sereflo
Type: Inhaler
Start date: 1 August 2021
End date: 31 July 2023
Aligned to PrescQIPP: Yes
Insulin: Aprida
Company: Aventis Pharma Limited trading as Sanofi
Product: Aprida
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes
Product: Aprida
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes
Insulin: Insuman
Company: Aventis Pharma Limited trading as Sanofi
Product: Insuman
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes
Product: Insuman
Type: Insulin
Start date: 1 April 2021
End date: 31 March 2022
Aligned to PrescQIPP: Yes
Insulin: Lispro
Company: Aventis Pharma Limited trading as Sanofi
Product: Lispro
Type: Insulin
Start date: 1 April 2020
End date: 30 September 2021
Aligned to PrescQIPP: Yes
Product: Lispro
Type: Insulin
Start date: 1 April 2020
End date: 30 September 2021
Aligned to PrescQIPP: Yes
Pain relief patch: Fencino
Company: DS Ashbourne Limited (Part of the Ethypharm Group)
Product: Fencino
Type: Pain relief patch
Start date: 1 April 2016
End date: Rolling
Aligned to PrescQIPP: Yes
Product: Fencino
Type: Pain relief patch
Start date: 1 April 2016
End date: Rolling
Aligned to PrescQIPP: Yes
Parkinson's: Pipexus
Company: Ethypharm
Product: Pipexus
Type: For use in the treatment of Parkinson’s
Start date: 1 July 2018
End date: Rolling
Aligned to PrescQIPP: Yes
Product: Pipexus
Type: For use in the treatment of Parkinson’s
Start date: 1 July 2018
End date: Rolling
Aligned to PrescQIPP: Yes
Prostate cancer: Firmagon® (degarelix)
Company: Ferring Pharmaceauticals
Product: Firmagon® (degarelix)
Type: Treatment for prostate cancer
Start date: 1 September 2019
End date: 31 August 2020
Aligned to PrescQIPP: Yes
Product: Firmagon® (degarelix)
Type: Treatment for prostate cancer
Start date: 1 September 2019
End date: 31 August 2020
Aligned to PrescQIPP: Yes
